Facilitated By

San Antonio Medical Foundation

Trending Research

Top viewed research performed by San Antonio Bioscience Organizations


To evaluate molecular relapse free rates 6 months after stopping nilotinib therapy in patients who achieve MR4.5

Brooke Army Medical Center
Email for information

The goal of this clinical research study is to learn the most effective way to give patients a vaccine in order for the immune system to react against folate binding protein (FBP) and FBP-containing cancers. The E39 and J65 peptide (a piece of a protein) vaccines are designed to cause the immune system to attack certain cancer cells (those with FBP), which may help lower the risk that the cancer will come back.

Cancer Insight, LLC
George Peoples